Michael R. Jeune

Effect of Matrix Metalloproteinase Inhibition on Progression of Atherosclerosis and Aneurysm in LDL Receptor‐Deficient Mice Overexpressing MMP‐3, MMP‐12, and MMP‐13 and on Restenosis in Rats after Balloon Injury

Margaret F. Prescott, Wilbur K. Sawyer, JEAN VON LINDEN‐REED et al. · Annals of the New York Academy of Sciences · 1999 · 143 citations

Medicine, Cardiology, Pharmacology +14

Discovery, Synthesis, and Biological Evaluation of Thiazoloquin(az)olin(on)es as Potent CD38 Inhibitors

Curt D. Haffner, J. David Becherer, Eric E. Boros et al. · Journal of Medicinal Chemistry · 2015 · 136 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Identification and Characterization of 4-Chloro-<i>N</i>-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist

Barry G. Shearer, Robert W. Wiethe, Adam Ashe et al. · Journal of Medicinal Chemistry · 2010 · 79 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of 3-Aryl-4-isoxazolecarboxamides as TGR5 Receptor Agonists

Karen A. Evans, Brian Budzik, Sean Ross et al. · Journal of Medicinal Chemistry · 2009 · 75 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Discovery of 4-Amino-8-quinoline Carboxamides as Novel, Submicromolar Inhibitors of NAD-Hydrolyzing Enzyme CD38

J. David Becherer, Eric E. Boros, Tiffany Carpenter et al. · Journal of Medicinal Chemistry · 2015 · 56 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12